Trial Sponsors Seek New Countries As Russian Market ‘Falls Into The Abyss’
Executive Summary
The Russian clinical trials organization ACTO says the “gloomy” prospects for multinational clinical trials in the country have led many sponsors to postpone the initiation of new studies or abandon them entirely in favor of other markets.
You may also be interested in...
Russian Clinical Trials Plunge To Lowest Point In 19 Years Following Ukraine War
The second half of 2022 confirmed the slump in clinical trial activity in Russia that was seen in the first half of the year following the country's decision to invade Ukraine, and many of the trials approved that year are not expected to go ahead.
EU Advises Use Of Pandemic Flexibilities For Trials In Ukraine
Amid the continuing conflict and the Russian shelling of hospitals in Ukraine, regulatory bodies, health authorities and clinical research organizations are issuing guidance on how to deal with the impact on clinical trials in both Ukraine and Russia.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.